SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Karminder Gill, Jeffrey C. Fink, David T. Gilbertson, Keri L. Monda, Paul Muntner, Richard A. Lafayette, Jeffrey Petersen, Glenn M. Chertow, Brian D. Bradbury, Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease, Pharmacoepidemiology and Drug Safety, 2015, 24, 5
  2. 2
    Francesco Salvo, Stefania Antoniazzi, Mai Duong, Mathieu Molimard, Fabienne Bazin, Annie Fourrier-Réglat, Antoine Pariente, Nicholas Moore, Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies, Expert Opinion on Drug Safety, 2014, 13, 5, 573

    CrossRef

  3. 3
    Halit Zengin, Süleyman Kaplan, Levent Tümkaya, Berrin Zühal Altunkaynak, Murat Çetin Rağbetli, Muhammed Eyüp Altunkaynak, Özcan Yılmaz, Effect of prenatal exposure to diclofenac sodium on the male rat arteries: a stereological and histopathological study, Drug and Chemical Toxicology, 2013, 36, 1, 67

    CrossRef

  4. 4
    K. S. Gill, P. Muntner, R. A. Lafayette, J. Petersen, J. C. Fink, D. T. Gilbertson, B. D. Bradbury, Red blood cell transfusion use in patients with chronic kidney disease, Nephrology Dialysis Transplantation, 2013, 28, 6, 1504

    CrossRef

  5. 5
    Fei Xue, Indiana Strombom, Bruce Turnbull, Shao Zhu, John Seeger, Treatment With Duloxetine in Adults and the Incidence of Cardiovascular Events, Journal of Clinical Psychopharmacology, 2012, 32, 1, 23

    CrossRef

  6. 6
    Robin S. Turpin, Todd Canada, Frank Xiaoqing Liu, Catherine J. Mercaldi, Alessandro Pontes-Arruda, Paul Wischmeyer, Nutrition Therapy Cost Analysis in the US, Applied Health Economics and Health Policy, 2011, 9, 5, 281

    CrossRef

  7. 7
    S. J. Reisinger, P. B. Ryan, D. J. O'Hara, G. E. Powell, J. L. Painter, E. N. Pattishall, J. A. Morris, Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases, Journal of the American Medical Informatics Association, 2010, 17, 6, 652

    CrossRef

  8. 8
    Keith D. Coon, Landon J. Inge, Kristen Swetel, Valerie Felton, Phillip Stafford, Ross M. Bremner, Genomic characterization of the inflammatory response initiated by surgical intervention and the effect of perioperative cyclooxygenase 2 blockade, The Journal of Thoracic and Cardiovascular Surgery, 2010, 139, 5, 1253

    CrossRef

  9. 9
    Alexander M. Walker, Signal detection for vaccine side effects that have not been specified in advance, Pharmacoepidemiology and Drug Safety, 2010, 19, 3
  10. You have free access to this content10
    Arduino A. Mangoni, Richard J. Woodman, Paraskevi Gaganis, Andrew L. Gilbert, Kathleen M. Knights, Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community, British Journal of Clinical Pharmacology, 2010, 69, 6
  11. 11
    Sebastian Schneeweiss, Soko Setoguchi, M. Alan Brookhart, Liljana Kaci, Philip S. Wang, Assessing Residual Confounding of the Association between Antipsychotic Medications and Risk of Death using Survey Data, CNS Drugs, 2009, 23, 2, 171

    CrossRef

  12. 12
    Najat Ziyadeh, Andrew T. McAfee, Carol Koro, Joan Landon, K. Arnold Chan, The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: A retrospective cohort study using a US health insurance database, Clinical Therapeutics, 2009, 31, 11, 2665

    CrossRef

  13. 13
    Jeffrey R. Curtis, Hong Cheng, Elizabeth Delzell, David Fram, Meredith Kilgore, Kenneth Saag, Huifeng Yun, William DuMouchel, Adaptation of Bayesian Data Mining Algorithms to Longitudinal Claims Data, Medical Care, 2008, 46, 9, 969

    CrossRef

  14. 14
    Carlos A. Zarate, Husseini K. Manji, Bipolar disorder: candidate drug targets, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2008, 75, 3
  15. 15
    Marianne Cunnington, David Webb, Nawab Qizilbash, David Blum, Adrian Mander, Michele Jonsson Funk, John Weil, Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis, Pharmacoepidemiology and Drug Safety, 2008, 17, 6
  16. 16
    James E Frampton, Gillian M Keating, Celecoxib, Drugs, 2007, 67, 16, 2433

    CrossRef

  17. 17
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2007, 16, 1
  18. 18
    J S Almenoff, E N Pattishall, T G Gibbs, W DuMouchel, S J W Evans, N Yuen, Novel Statistical Tools for Monitoring the Safety of Marketed Drugs, Clinical Pharmacology & Therapeutics, 2007, 82, 2
  19. 19
    Rachael E. Eckert, Laura E. Neuder, Jennifer L. Bell, Jennifer C. Trujillo, Samuel L. Jones, The role of p38 mitogen-activated kinase (MAPK) in the mechanism regulating cyclooxygenase gene expression in equine leukocytes, Veterinary Immunology and Immunopathology, 2007, 118, 3-4, 294

    CrossRef

  20. 20
    L-C. Chen, D. M. Ashcroft, Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials, Journal of Clinical Pharmacy and Therapeutics, 2006, 31, 6
  21. 21
    Antonio González-Pérez, Luis Alberto García Rodriguez, Cardiovascular Toxicities of NSAIDS: Epidemiologic Aspects,
  22. 22
    K. Arnold Chan, Nonsteroidal Anti-inflammatory Drugs – Cyclooxygenase-2 Inhibitors: Risks and Benefits,
  23. 23
    Rodrigo Machado-Vieira, Ioline Henter, Jacqueline Baumann, David Latov, Cristina Wheeler-Castillo, Carlos A. Zarate, Novel Therapeutic Approaches for Treating Bipolar Disorder,
  24. 24
    Rodrigo Machado-Vieira, Husseini K. Manji, Carlos A. Zarate, Novel Therapeutic Strategies for Bipolar Disorder,